Américo Ceiki Sakamoto

Américo Ceiki Sakamoto

Auto-generated profile, based on publicly available information

Américo Ceiki Sakamoto

Department of Neurosciences and Behaviour Sciences Universidade de São Paulo, Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto Ribeirão Preto São Paulo Brazil

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2014 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
ASANTONIO CARLOS DOS SANTOS
ANTONIO CARLOS DOS SANTOS
SESara Escorsi-Rosset
Sara Escorsi-Rosset
GSGustavo N. Simao
Gustavo N. Simao
VTVera C. Terra
Vera C. Terra
TVTonicarlo Velasco
Tonicarlo Velasco
HMHélio Rubens Machado
Hélio Rubens Machado

1 August 2006 in Epilepsy & Behavior
Verified
Journal Article
Closed access
NANeide Barreira Alonso
Neide Barreira Alonso
RCRozana Mesquita Ciconelli
Rozana Mesquita Ciconelli
TSTatiana Indelicato da Silva
Tatiana Indelicato da Silva
AWAna Carolina Westphal-Guitti
Ana Carolina Westphal-Guitti
AAAuro Mauro Azevedo
Auro Mauro Azevedo
EYElza Márcia Targas Yacubian
Elza Márcia Targas Yacubian

1 June 2006 in Journal of Epilepsy and Clinical Neurophysiology
Verified
Journal Article
Open access
PDF file
VRVivianne Pellegrino Rosa
Vivianne Pellegrino Rosa
GAGerardo Maria Araujo-Filho
Gerardo Maria Araujo-Filho
MRMárcio Andriani Rahal
Márcio Andriani Rahal
LCLuís Otávio Sales Ferreira Caboclo
Luís Otávio Sales Ferreira Caboclo
ASAmérico Ceiki Sakamoto
Américo Ceiki Sakamoto
EYElza Márcia T. Yacubian
Elza Márcia T. Yacubian
INTRODUCTION: Ictal fear (IF) is one of the most frequent emotional auras. It is the sole or predominant manifestation of simple partial seizures or initial expression of a complex partial seizure. It is more often experienced in patients with mesial temporal lobe epilepsy (TLE), probably associated with mesial temporal structures, like the amygdala. Anxiety disorders are very common psychiatric disorders associated with epilepsy, with a prevalence of 15 to 25%. OBJECTIVES: To describe three patients with IF with refractory mesial TLE, also presenting the results of EEG, imaging exams, neuropsychological, quality of life and psychiatric evaluations. METHODS AND RESULTS: Three case reports of patients with refractory mesial TLE and IF followed up in the outpatient's clinic at the Epilepsy Section, Universidade Federal de São Paulo, Brazil, were submitted to presurgical evaluation and corticoamygdalohippocampectomy. Two patients presented ictal scalp-sphenoidal EEG onset on left side. Two patients had major depressive disorder in psychiatric evaluation. CONCLUSION: Although IF is the most frequent ictal psychological symptom, anxiety and mood disorders are very common psychiatric comorbidity in patients with epilepsy. It was concluded that differential diagnosis of interictal anxiety disorders, panic attacks and IF can be difficult, and requires careful management.

1 December 2006 in Journal of Epilepsy and Clinical Neurophysiology
Verified
Journal Article
Open access
PDF file
MMMarcele Araujo Silva Mantoan
Marcele Araujo Silva Mantoan
TSTatiana Indelicato da Silva
Tatiana Indelicato da Silva
NANeide Barreira Alonso
Neide Barreira Alonso
MNMaria Helena da Silva Noffs
Maria Helena da Silva Noffs
CMCarolina Mattos Marques
Carolina Mattos Marques
EYElza Márcia Targas Yacubian
Elza Márcia Targas Yacubian
INTRODUCTION: Epilepsy is a disorder that results in abnormal activity in a group of neurons that may have significant impact on the normal cognitive processes and behavior. Temporal lobe epilepsy (TLE) is the most frequent form of partial epilepsy in adults, and hippocampal sclerosis (HS) the most common neuropathologic finding in patients with medically refractory TLE. Patients with TLE often present cognitive difficulties that may be determined by the effects of epileptic discharges and side of the lesion. And its consequence is that patients have poor effects on quality of life (QOL). PURPOSE: We report the relationship between neuropsychological assessment and QOL under the hypotheses that patients with worst results in neuropsychological assessment have poorer QOL assessed by the QOLIE-31. RESULTS: Regarding seizure frequency, 23 (46%) had had 1-5, 20 (40%) 6-10 and 7 (14%) more than 10 seizures/month. In relation to seizure types, 5 (10%) had had auras, 37 (74%) complex partial seizures and 8 (16%) partial evolving to generalized tonic-clonic seizures (GTCS). Neuropsychological evaluation had a positive correlation with QOLIE-31 domains. QOL evaluations had the worst scores in QOLIE-31 were in Cognitive Function (45.0) and Social Function (46.0). The best was Overall QOL (62.0). CONCLUSION: People with epilepsy have great impact on their QOL not only because of daily seizures but because of the impact seizures cause in their cognitive functions. TLE is an example of how refractory epilepsy can exterminate any possibilities of work, study and live in a society that discriminates someone with epilepsy who also presents cognitive decline.

1 October 2012 in Revista de Nutrição
Verified
Journal Article
Open access
PDF file
LMLuciana Duarte Martins
Luciana Duarte Martins
VTVera Cristina Terra
Vera Cristina Terra
CFCarolina Ferreira
Carolina Ferreira
PCPaula Garcia Chiarello
Paula Garcia Chiarello
JMJulio Sergio Marchini
Julio Sergio Marchini
CNCarla Nonino
Carla Nonino
OBJECTIVE:The ketogenic diet is used as a therapeutic alternative for the treatment of epilepsy in patients with refractory epilepsy. It simulates biochemical changes typical of fasting. The present study verified the nutritional impact of the ketogenic diet on children with refractory epilepsy. METHODS: Nutritional status data (dietary, biochemical and anthropometric measurements), seizure frequency, and adverse events were collected from the medical records and during outpatient clinic visits of children over a period of 36 months. RESULTS: Of the 29 children who initiated the ketogenic diet, 75.8% presented fewer seizures after one month of treatment. After six months, 48.3% of the patients had at least a 90.0% decrease in seizure frequency, and 50.0% of these patients presented total seizure remission. At 12 months, eight patients continued to show positive results, and seven of these children remained on the ketogenic diet for 24 months. There was an improvement of the nutritional status at 24 months, especially in terms of weight, which culminated with the recovery of proper weightforheight. There were no significant changes in biochemical indices (total cholesterol and components, triglycerides, albumin, total protein, creatinine, glycemia, serum aspartate transaminase and serum alanine transaminase). Serum cholesterol levels increased significantly in the first month, fell in the following six months, and remained within the normal limits thereafter. CONCLUSION: In conclusion, patients on the classic ketogenic diet for at least 24 months gained weight. Moreover, approximately one third of the patients achieved significant reduction in seizure frequency, and some patients achieved total remission.

8 October 2026 in Epileptic Disorders
Verified
Journal Article
Open access
PDF file
TFTomásia Oliveira de Holanda Monteiro Frezatti
Tomásia Oliveira de Holanda Monteiro Frezatti
RSRicardo L. Saute
Ricardo L. Saute
VJVeriano Alexandre Júnior
Veriano Alexandre Júnior
FNFrederico N. Nakano
Frederico N. Nakano
MDMarina T. R. P. Dalio
Marina T. R. P. Dalio
ASAmérico C. Sakamoto
Américo C. Sakamoto
Objective: To evaluate the feasibility of investigating autoimmune etiology in adults with drug‐resistant epilepsy (DRE) of unknown origin in resource‐limited settings and to develop a pragmatic, hypothesis‐generating screening approach to guide autoantibody testing. Methods: A prospective observational study including adults with DRE of unknown etiology was conducted at a tertiary epilepsy center in Brazil. All patients underwent standardized assessment including inflammatory and autoimmunity markers, brain magnetic resonance imaging (MRI), electroencephalography (EEG), cerebrospinal fluid (CSF) analysis, and application of the APE2 and ACES scores. Clinical, laboratory, and imaging findings were analyzed in the context of published autoimmune‐associated epilepsy (AAE) profiles to inform a pragmatic screening strategy. Results: Twenty‐six patients (46.2% female; median epilepsy duration: 18.5 years) were included. EEG findings were nonspecific. Six patients developed mesial temporal abnormalities on follow‐up MRI. CSF protein elevation was observed in 37.5%, oligoclonal bands in 13.6%, and elevated IgG index in 18.2%. Antinuclear antibodies were detected in 26.9%. APE2 score ≥ 4 was present in 57.7%, while ACES score ≥ 2 occurred in 11.5%. Due to limited access to antibody testing, only one patient underwent CSF autoantibody analysis, confirming high‐titer anti‐GAD65. Based on integrated clinical, laboratory, and imaging findings, a pragmatic screening algorithm was proposed to prioritize candidates for autoantibody testing. Significance: In resource‐limited settings, systematic use of accessible clinical and laboratory markers may help identify patients with higher pre‐test probability of AAE. A pragmatic screening approach may improve diagnostic efficiency and support individualized decision‐making when comprehensive antibody testing is not readily available.